Data Transmission Vulnerability in Baxter Medical Devices
CVE-2020-12036

7.5HIGH

Key Information:

Vendor

Baxter

Status
Baxter Prismaflex And Prismax
Vendor
CVE Published:
29 June 2020

What is CVE-2020-12036?

Baxter medical devices, specifically PrismaFlex and PrisMax, fail to utilize data-in-transit encryption when transmitting treatment data to Patient Data Management Systems (PDMS) or Electronic Medical Record (EMR) systems. This oversight allows potential attackers to intercept and observe sensitive patient data during transmission, raising significant concerns regarding patient confidentiality and data integrity.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Baxter PrismaFlex and PrisMax PrismaFlex all versions, PrisMax all versions prior to 3.x

References

https://www.us-cert.gov/ics/advisories/icsma-20-170-01
x_refsource_MISC

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.